Free Trial
NASDAQ:VANI

Vivani Medical Q1 2025 Earnings Report

Vivani Medical logo
$1.25 -0.01 (-0.79%)
As of 01:14 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Vivani Medical EPS Results

Actual EPS
-$0.11
Consensus EPS
-$0.10
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

Vivani Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Vivani Medical Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Tuesday, May 13, 2025
Conference Call Time
12:00AM ET

Upcoming Earnings

Vivani Medical's Q2 2025 earnings is scheduled for Tuesday, August 12, 2025

Vivani Medical Earnings Headlines

3 Penny Stocks With Market Caps Over $30M To Consider
Top Picks for Trump’s Pro-Crypto America
27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your spot for FREE.
See More Vivani Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Vivani Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vivani Medical and other key companies, straight to your email.

About Vivani Medical

Vivani Medical (NASDAQ:VANI), a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

View Vivani Medical Profile

More Earnings Resources from MarketBeat